GENTIUM SPA ADR (NASDAQ: GENT)





$1.85 0.07 (3.93%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
4.00
52-Week Low Price
0.28
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.03 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-0.50
Shares
14.96 M
Dividend Rate ($) / (%)
0.00/0.00
67%
33%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 214% - GENT has outperformed the S&P 500 by 188%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
MEDICAL NUTRITION USA (MDNU) $1.95 -  $0.25(11.36%)0.03 B
AMARIN CORP PLC ADS (AMRN) $1.06 -  $0.03(2.75%)0.03 B
SUNESIS PHARMACEUTICALS (SNSS) $0.84 -  $0.01(1.32%)0.03 B
QUIGLEY CORP THE (QGLY) $2.09 -  $0.00(0.00%)0.03 B
INTERLEUKIN GENETICS INC (ILI) $0.86 -  $0.03(3.18%)0.03 B
CARDIOVASCULAR BIOTHER... (CVBT) $0.17 -  $0.00(0.00%)0.03 B
CELLCEUTIX CORP (CTIX) $0.43 -  $0.00(0.00%)0.03 B
PRANA BIOTECH ADR (PRAN) $1.29 -  $0.04(3.10%)0.03 B
GTC BIOTHERAPEUTICS INC (GTCB) $1.05 -  $0.01(0.94%)0.03 B
RENHUANG PHARMACEUTICA... (RHGP) $1.45 -  $0.05(3.33%)0.03 B
STOCK ANALYSIS
There are currently no Stock Analysis.
GENT RELATED HEADLINES
arrow
Gentium Provides an Update on the Phase 3 Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
Gentium Provides an Update on the Phase 3 Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease

At BusinessWire 11/19/2008
arrow
Gentium Announces that Italian Court Rejects Plaintiffs' Claims and Ends Legal Proceeding
Gentium Announces that Italian Court Rejects Plaintiffs' Claims and Ends Legal Proceeding

At BusinessWire 10/2/2008
arrow
Gentium Announces Italian Legal Proceeding
Gentium Announces Italian Legal Proceeding

At BusinessWire 8/26/2008
arrow
Gentium Reports First Quarter Financial Results; Provides Financial and Clinical Update
Gentium Reports First Quarter Financial Results; Provides Financial and Clinical Update

At BusinessWire 6/26/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2